Literature DB >> 8575477

Technetium-99m mercaptoacetyltriglycine clearance: reference values for infants and children.

O Schofer1, G König, U Bartels, A Bockisch, R Piepenburg, R Beetz, G Meyer, K Hahn.   

Abstract

Six hundred and thirty-nine clearance studies performed in children aged 7 days to 19 years utilizing technetium-99m mercaptoacetyltriglycine (MAG 3) were retrospectively analysed. Standardized conditions for the investigation included: parenteral hydration (60 ml/hxm2 body surface) in addition to normal oral fluid intake, weight-related dose of 99mTc-MAG 3 (1 MBq/kg body weight, minimum 15 MBq) and calculation of clearance according to Bubeck et al. Of the 513 children, 169 included in this analysis could be classified as "normal" with regard to their renal function. Normal kidney function was judged by the following criteria: normal GFR for age, normal tubular function (absence of proteinuria and glucosuria), normal renal parenchyma (on ultrasonography, MAG 3 scan and intravenous pyelography), absence of significant obstruction and gross reflux (>grade I), no single kidney and no difference in split renal function >20%. Results showed increasing MAG 3 clearance values for infants during the first months of life, reaching the normal range for older children and adults between 7 and 12 months.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8575477     DOI: 10.1007/bf00801613

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

Review 1.  Paediatric nuclear medicine.

Authors:  A Piepsz; I Gordon; K Hahn
Journal:  Eur J Nucl Med       Date:  1991

Review 2.  Transitional nephrology.

Authors:  C L Stewart; P A Jose
Journal:  Urol Clin North Am       Date:  1985-02       Impact factor: 2.241

3.  [Formula creatinine clearance as a substitute for 24-hour creatine clearance in children with kidney transplantation].

Authors:  C Aufricht; A Balbisi; C Gerdov; T Müller; M A Lothaller; E Balzar
Journal:  Klin Padiatr       Date:  1995 Mar-Apr       Impact factor: 1.349

4.  A new principle to normalize plasma concentrations allowing single-sample clearance determinations in both children and adults.

Authors:  B Bubeck; R Piepenburg; U Grethe; B Ehrig; K Hahn
Journal:  Eur J Nucl Med       Date:  1992

5.  New formulas for the calculation of effective renal plasma flow.

Authors:  W N Tauxe; E V Dubovsky; T Kidd; F Diaz; L R Smith
Journal:  Eur J Nucl Med       Date:  1982

6.  Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.

Authors:  M Stabin; A Taylor; D Eshima; W Wooter
Journal:  J Nucl Med       Date:  1992-01       Impact factor: 10.057

7.  The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents.

Authors:  G J Schwartz; L P Brion; A Spitzer
Journal:  Pediatr Clin North Am       Date:  1987-06       Impact factor: 3.278

8.  Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.

Authors:  A R Fritzberg; S Kasina; D Eshima; D L Johnson
Journal:  J Nucl Med       Date:  1986-01       Impact factor: 10.057

9.  Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.

Authors:  A Taylor; D Eshima; P E Christian; W Milton
Journal:  Radiology       Date:  1987-02       Impact factor: 11.105

  9 in total
  1 in total

1.  Evaluation of (123)I-orthoiodohippurate single kidney clearance rate by renal sequential scintigraphy in a large cohort of likely normal subjects aged between 0 and 18 years.

Authors:  Alessio Imperiale; Catia Olianti; Giannetto Comis; Giuseppe La Cava
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-28       Impact factor: 10.057

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.